ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >3-O-Decladinosyl-6-O-Methylerythronolide A
3-O-Decladinosyl-6-O-Methylerythronolide A

- CAS No.
- 118058-74-5
- Chemical Name:
- 3-O-Decladinosyl-6-O-Methylerythronolide A
- Synonyms
- DesclarithoMycin;3-hydroxyclarithromycin;Clarithromycin Impurity I;Clarithromycin EP Impurity I;De(cladinosyl) ClarithroMycin;Des(cladinosyl) Clarithromycin;Clarithromycin related compound I;(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R);5-O-DesosaMinyl-6-O-Methylerythronolide A;3-O-Decladinosyl-6-O-methylerythromycin A
- CBNumber:
- CB02620909
- Molecular Formula:
- C30H55NO10
- Molecular Weight:
- 589.77
- MOL File:
- 118058-74-5.mol
- Modify Date:
- 2023/5/4 15:15:35
Melting point | 158-160 °C |
---|---|
Boiling point | 708.6±60.0 °C(Predicted) |
Density | 1.17±0.1 g/cm3(Predicted) |
storage temp. | Hygroscopic, -20°C Freezer, Under Inert Atmosphere |
solubility | Chloroform (Slightly), Methanol (Slightly) |
form | Solid |
pka | 13.10±0.70(Predicted) |
color | White to Off-White |
SAFETY
Risk and Safety Statements
Symbol(GHS) | ![]() GHS07 |
---|---|
Signal word | Warning |
Hazard statements | H319 |
Precautionary statements | P264-P280-P305+P351+P338-P337+P313P |
3-O-Decladinosyl-6-O-Methylerythronolide A Preparation Products And Raw materials
Raw materials
Preparation Products
Global( 86)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
SynThink RESEARCH CHEMICALS | +91-8177860948 +91-8177860948 | Mumbai, India | 494 | 58 | Inquiry |
Aavyan Labs | +91-9652399498 +91-9652399498 | Telangana, India | 60 | 58 | Inquiry |
Allmpus Laboratories Pvt Ltd | +91-9518738415 +91-9167862134 | Maharashtra, India | 657 | 58 | Inquiry |
Anant Pharmaceuticals Pvt. ltd | +91 8550986868 | Maharashtra, India | 736 | 58 | Inquiry |
Pharma Affiliates | 172-5066494 | Haryana, India | 6754 | 58 | Inquiry |
CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6257 | 58 | Inquiry |
SynZeal Research Pvt Ltd | +1 226-802-2078 | Gujarat, India | 6514 | 58 | Inquiry |
Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6739 | 58 | Inquiry |
Equilife Laboratories Private Limited | 08046060585 | Pune, India | 47 | 58 | Inquiry |
career henan chemical co | +86-0371-86658258 +8613203830695 | China | 29858 | 58 | Inquiry |
118058-74-5(3-O-Decladinosyl-6-O-Methylerythronolide A)Related Search:
Clarithromycin Impurity Q (10 mg) (N-oxide clarithromycin)
6,11-Di-O-Methyl ErythroMycin
ClarithroMycin IMpurity G
4'',6-Di-O-MethylerythroMycin
Clarithromycin
chevron_left
1of3
chevron_right
3-O-De(2,6-dideoxy-3-C-Methyl-3-O-Methyl-α-L-ribo-hexopyranosyl)-6-O-MethylerythroMycin
5-O-DesosaMinyl-6-O-Methylerythronolide A
De(cladinosyl) ClarithroMycin
DesclarithoMycin
Des(cladinosyl) Clarithromycin
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-4,12,13-trihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecan
Clarithromycin Impurity 9(Clarithromycin EP Impurity I)
Clarithromycin EP Impurity I
Clarithromycin Impurity I
Clarithromycin related compound I
3-hydroxyclarithromycin
Clarithromycin EP Impurity I/(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-4,12,13-trihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)
Erythromycin, 3-O-de(2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl)-6-O-methyl-
Clarithromycin EP Impurity I (Des(cladinosyl) Clarithromycin/ 3-O-Decladinosyl-6-O-methylerythromycin A)
3-O-Decladinosyl-6-O-methylerythromycin A
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(Dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-4,12,13-trihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione (Clarithromycin Impurity)
Clarithromycin related compound I, EvoPure
Decladinosyl Clarithromycin (25 mg) (3-O-De(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)-6-O-methylerythromycin
3-O-Decladinosyl-6-O-Methylerythronolide A
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-4,12,13-trihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-(((2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-14-ethyl-4,12,13-trihydroxy-7-methoxy-3,5,7,9,11,13-hexamethyloxacyclotetradeca
(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane
118058-74-5
C30H55NO10
Chiral Reagents, Impurities, Pharmaceuticals, Intermediates & Fine Chemicals
Chiral Reagents
Impurities
Intermediates & Fine Chemicals
Pharmaceuticals